Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | LIPE | Q05469 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 4/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29937368 | 0.87 | FFAR1 (0.50) | FFAR1MAPTMAPK1TDP1L3MBTL1 | |
| SCHEMBL18893984 | 0.87 | FFAR1 (0.50) | FFAR1MAPTMAPK1TDP1L3MBTL1 | |
| SCHEMBL13504468 | 0.85 | FFAR1 (0.49) | FFAR1MAPTMAPK1TDP1L3MBTL1 | |
| SCHEMBL17547014 | 0.85 | SLC6A4 (0.54) | FFAR1MAOB | |
| SCHEMBL5109981 | 0.85 | FFAR1 (0.56) | FFAR1MAOB | |
| SCHEMBL28843836 | 0.84 | FFAR1 (0.59) | FFAR1MAPTMAPK1TDP1L3MBTL1 | |
| SCHEMBL10471107 | 0.84 | FFAR1 (0.48) | FFAR1MAPTMAPK1TDP1L3MBTL1 | |
| SCHEMBL74678 | 0.83 | MAPT (0.59) | FFAR1MAPTMAPK1TDP1L3MBTL1 | |
| SCHEMBL23663419 | 0.82 | FFAR1 (0.47) | FFAR1MAPTMAPK1TDP1L3MBTL1 | |
| SCHEMBL584956 | 0.81 | HTR1A (0.46) | FFAR1MAPTMAPK1TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190055193-A1 | High-Solubility Thioether Quinones | U.S. DEPARTMENT OF ENERGY | 2019-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190055193-A1 | High-Solubility Thioether Quinones | SQOR, TST, NDUFS3 | FFAR1 2475/4885MAPT 3999/4885MAPK1 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.